Epigenetics, I GF2 dosage and cancer risk

Kaneda; Feinberg; Iacobuzio-Donahue; Takashi Sakatani; Sten De Boom Witzel; Mark Carter; Minoru Ko; Dan Longo; Hideyuki Okano; Ohlsson

Epigenetics, I GF2 dosage and cancer risk

Kaneda, Feinberg, Iacobuzio-Donahue, Takashi Sakatani, Sten De Boom Witzel, Mark Carter, Minoru Ko, Dan Longo, Hideyuki Okano, Ohlsson

生理学

研究成果: Comment/debate › 査読

本文言語	English
ジャーナル	Cancer Biology and Therapy
巻	4
号	3
出版ステータス	Published - 2005 3月 1

ASJC Scopus subject areas

分子医療
腫瘍学
薬理学
癌研究

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

他のファイルとリンク

引用スタイル

@article{996d9d51e9584b089eadac3a2b3cb54e,

title = "Epigenetics, I GF2 dosage and cancer risk",

author = "Kaneda and Feinberg and Iacobuzio-Donahue and Takashi Sakatani and Witzel, {Sten De Boom} and Mark Carter and Minoru Ko and Dan Longo and Hideyuki Okano and Ohlsson",

year = "2005",

month = mar,

day = "1",

language = "English",

volume = "4",

journal = "Cancer Biology and Therapy",

issn = "1538-4047",

publisher = "Landes Bioscience",

number = "3",

}

TY - JOUR

T1 - Epigenetics, I GF2 dosage and cancer risk

AU - Kaneda,

AU - Feinberg,

AU - Iacobuzio-Donahue,

AU - Sakatani, Takashi

AU - Witzel, Sten De Boom

AU - Carter, Mark

AU - Ko, Minoru

AU - Longo, Dan

AU - Okano, Hideyuki

AU - Ohlsson,

PY - 2005/3/1

Y1 - 2005/3/1

UR - http://www.scopus.com/inward/record.url?scp=25144487169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25144487169&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:25144487169

SN - 1538-4047

VL - 4

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

IS - 3

ER -